Squarepoint
THRD

Squarepoint’s Third Harmonic Bio THRD Stock Holding History

Squarepoint’s Portfolio THRD Stock Details THRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-51,099
Closed -$277K – 4995
2025
Q2 		$277K Sell
51,099
-70,833
-58% -$353K ﹤0.01% 3752
2025
Q1 		$423K Buy
121,932
+102,747
+536% +$498K ﹤0.01% 3460
2024
Q4 		$197K Buy
+19,185
New +$239K ﹤0.01% 4482
2024
Q3 		– Sell
-32,178
Closed -$418K – 4699
2024
Q2 		$418K Buy
32,178
+1,767
+6% +$21.9K ﹤0.01% 3209
2024
Q1 		$287K Buy
+30,411
New +$296K ﹤0.01% 3423
2023
Q1 		– Sell
-13,912
Closed -$59.8K – 3813
2022
Q4 		$59.8K Sell
13,912
-11,472
-45% -$192K ﹤0.01% 3034
2022
Q3 		$482K Buy
+25,384
New +$457K ﹤0.01% 2220

Other funds holding THRD

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
JC
JBF Capital Aspen, Colorado $676M AUM 24.74% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
AB
Amalgamated Bank New York $13.1B AUM 29.66% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Squarepoint's THRD Position: Q3 2025 in Review

Squarepoint sold out of Third Harmonic Bio (THRD) in Q3 2025, closing a stake of 51,099 shares — an estimated $277K sold.

Squarepoint first reported a position in THRD in Q3 2022 and held it in 7 quarters. The position peaked at $482K in Q3 2022. 18 funds tracked by Wall St. Rank hold THRD as of Q3 2025.

  • Squarepoint reported no remaining Third Harmonic Bio position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 51,099 Third Harmonic Bio shares in Q3 2025, an estimated $277K.
  • Squarepoint first reported a position in Third Harmonic Bio in Q3 2022 and held it in 7 quarters.
  • Squarepoint's Third Harmonic Bio position peaked at $482K in Q3 2022.
  • 18 funds tracked by Wall St. Rank held Third Harmonic Bio as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.